Dr. Wei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Boston, MA 02215
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2011 - 2013
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
MA State Medical License 2017 - 2026
NH State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer Start of enrollment: 2018 Oct 18
Roles: Principal Investigator, Contact
- Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy Start of enrollment: 2020 Dec 10
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors Start of enrollment: 2020 May 11
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 22 citationsHealth-related quality of life and pain outcomes with [Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant pr...Karim Fizazi, Ken Herrmann, Bernd J Krause, Kambiz Rahbar, Kim N Chi
The Lancet. Oncology. 2023-06-01 - 57 citationsSafety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma.Sarah Abou Alaiwi, Wanling Xie, Amin Nassar, Shaan Dudani, Dylan J. Martini
Journal for Immunotherapy of Cancer. 2020-02-01 - 1 citationsInsulin resistance during androgen deprivation therapy in men with prostate cancer.Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, Donald C Simonson, Alexander P Lin
Cancer. 2024-11-01
Press Mentions
Efficient Catalytic Reduction of Highly Toxic Aqueous Cr(VI) with Fe@CBC/Pd Composites at Room TemperatureOctober 16th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
